[PHARMA] YoY Annualized Quarter Result on 30-Jun-2010 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
11-Aug-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Jun-2010 [#2]
Profit Trend
QoQ- 29.23%
YoY- -25.34%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Revenue 1,875,944 1,806,964 1,563,526 1,335,790 1,293,856 1,326,230 1,112,932 9.08%
PBT 93,058 141,146 82,344 65,516 89,042 96,924 44,822 12.93%
Tax -30,410 -50,870 -23,056 -17,862 -22,610 -32,046 -17,402 9.74%
NP 62,648 90,276 59,288 47,654 66,432 64,878 27,420 14.74%
-
NP to SH 61,272 88,796 58,808 48,108 64,438 63,304 25,418 15.77%
-
Tax Rate 32.68% 36.04% 28.00% 27.26% 25.39% 33.06% 38.82% -
Total Cost 1,813,296 1,716,688 1,504,238 1,288,136 1,227,424 1,261,352 1,085,512 8.91%
-
Net Worth 481,681 481,282 451,381 417,306 400,063 362,623 314,515 7.35%
Dividend
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Div 35,323 35,301 - 100,581 57,763 38,508 32,093 1.60%
Div Payout % 57.65% 39.76% - 209.07% 89.64% 60.83% 126.26% -
Equity
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Net Worth 481,681 481,282 451,381 417,306 400,063 362,623 314,515 7.35%
NOSH 258,968 117,672 106,962 107,001 106,968 106,968 106,978 15.86%
Ratio Analysis
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
NP Margin 3.34% 5.00% 3.79% 3.57% 5.13% 4.89% 2.46% -
ROE 12.72% 18.45% 13.03% 11.53% 16.11% 17.46% 8.08% -
Per Share
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
RPS 724.39 1,535.58 1,461.75 1,248.38 1,209.56 1,239.83 1,040.34 -5.84%
EPS 23.66 75.46 54.98 44.96 60.24 59.18 23.76 -0.07%
DPS 13.64 30.00 0.00 94.00 54.00 36.00 30.00 -12.29%
NAPS 1.86 4.09 4.22 3.90 3.74 3.39 2.94 -7.34%
Adjusted Per Share Value based on latest NOSH - 106,939
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
RPS 130.16 125.38 108.49 92.68 89.77 92.02 77.22 9.08%
EPS 4.25 6.16 4.08 3.34 4.47 4.39 1.76 15.81%
DPS 2.45 2.45 0.00 6.98 4.01 2.67 2.23 1.57%
NAPS 0.3342 0.3339 0.3132 0.2895 0.2776 0.2516 0.2182 7.35%
Price Multiplier on Financial Quarter End Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Date 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 -
Price 4.49 10.18 5.90 4.98 3.80 3.27 3.53 -
P/RPS 0.62 0.66 0.40 0.40 0.31 0.26 0.34 10.52%
P/EPS 18.98 13.49 10.73 11.08 6.31 5.53 14.86 4.15%
EY 5.27 7.41 9.32 9.03 15.85 18.10 6.73 -3.99%
DY 3.04 2.95 0.00 18.88 14.21 11.01 8.50 -15.73%
P/NAPS 2.41 2.49 1.40 1.28 1.02 0.96 1.20 12.31%
Price Multiplier on Announcement Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Date 16/08/13 08/08/12 10/08/11 11/08/10 21/08/09 14/08/08 17/08/07 -
Price 4.66 8.83 5.90 4.95 4.00 3.44 3.44 -
P/RPS 0.64 0.58 0.40 0.40 0.33 0.28 0.33 11.66%
P/EPS 19.70 11.70 10.73 11.01 6.64 5.81 14.48 5.25%
EY 5.08 8.55 9.32 9.08 15.06 17.20 6.91 -4.99%
DY 2.93 3.40 0.00 18.99 13.50 10.47 8.72 -16.60%
P/NAPS 2.51 2.16 1.40 1.27 1.07 1.01 1.17 13.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment